A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 30, 2016

Conditions

Pruritus

Interventions

DRUG

SK-1405

Trial Locations (1)

Hammersmith Medicines Research, London

All Listed Sponsors

lead

Sanwa Kagaku Kenkyusho Co., Ltd.

INDUSTRY

NCT02650076 - A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects | Biotech Hunter | Biotech Hunter